Hemogenyx Pharmaceuticals Plc Stock Short Ratio
HEMO Stock | 343.40 20.90 6.48% |
Hemogenyx Pharmaceuticals PLC fundamentals help investors to digest information that contributes to Hemogenyx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Hemogenyx Stock. The fundamental analysis module provides a way to measure Hemogenyx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemogenyx Pharmaceuticals stock.
Hemogenyx | Short Ratio |
Hemogenyx Pharmaceuticals PLC Company Short Ratio Analysis
Hemogenyx Pharmaceuticals' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Based on the latest financial disclosure, Hemogenyx Pharmaceuticals PLC has a Short Ratio of 0.0 times. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United Kingdom stocks average (which is currently at 0.0).
Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
All Next | Launch Module |
Hemogenyx Fundamentals
Return On Equity | -1.56 | ||||
Return On Asset | -0.38 | ||||
Current Valuation | 13.18 M | ||||
Shares Outstanding | 3.5 M | ||||
Shares Owned By Insiders | 10.27 % | ||||
Shares Owned By Institutions | 0.79 % | ||||
Price To Book | 3.93 X | ||||
EBITDA | (5.73 M) | ||||
Net Income | (6.69 M) | ||||
Total Debt | 2.95 M | ||||
Book Value Per Share | 0 X | ||||
Cash Flow From Operations | (6.11 M) | ||||
Earnings Per Share | (2.00) X | ||||
Number Of Employees | 17 | ||||
Beta | 3.26 | ||||
Market Capitalization | 12.03 M | ||||
Total Asset | 6.11 M | ||||
Retained Earnings | (23.8 M) | ||||
Working Capital | 1.52 M | ||||
Net Asset | 6.11 M |
About Hemogenyx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemogenyx Pharmaceuticals PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.